Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Kinases regulate critical cellular functions and are often deregulated in cancer.
• Small-molecule kinase inhibitors are a key strategy in modern cancer therapeutics.
• Oxindole scaffolds are recognized for their potent multi-kinase inhibitory activities.

Purpose of the Study:

• To review recent advancements in oxindole-based kinase inhibitors for anticancer applications.
• To explore diverse oxindole structural frameworks and their kinase inhibition potential.
• To critically analyze design strategies, mechanisms of action, and structure-activity relationships (SARs).

Main Methods:

• Literature review of recent studies on oxindole-based kinase inhibitors.
• Analysis of distinguished structural frameworks: 3-alkenyl oxindoles, spirooxindoles, 3-iminooxindoles, and hydrazone derivatives.
• Evaluation of kinase inhibition potential, design strategies, SARs, and protein interactions.

Main Results:

• Oxindole scaffolds exhibit significant potential as privileged structures for multi-kinase inhibition.
• Specific frameworks like 3-alkenyl oxindoles and spirooxindoles demonstrate notable kinase inhibitory activity.
• Detailed SARs and interaction modes provide insights into rational drug design.

Conclusions:

• Oxindole-based compounds represent a promising class of anticancer therapeutics targeting kinase signaling pathways.
• Further research into oxindole derivatives can lead to novel, effective kinase inhibitors.
• Understanding SARs and molecular interactions is crucial for optimizing drug efficacy.